Progress and prospects on treatment of primary pulmonary carcinoid
10.3969/j.issn.1000-8179.2018.01.092
- VernacularTitle:原发性肺类癌的治疗进展与展望
- Author:
Xu SONG
1
,
2
;
Xiongfei LI
;
Jun CHEN
Author Information
1. 天津医科大学总医院肺部肿瘤外科 天津市300052
2. 天津市肺癌研究所
- Keywords:
pulmonary carcinoid;
neuroendocrine tumor;
diagnosis;
multidisciplinary treatment
- From:
Chinese Journal of Clinical Oncology
2018;45(1):47-52
- CountryChina
- Language:Chinese
-
Abstract:
Primary pulmonary carcinoid tumors are a group of relatively rare lung neoplasms.In the 2015 World Health Organization classification of lung tumors,lung carcinoid tumors(including both the classical and atypical types)were included in the category of pulmonary neuroendocrine tumors along with large cell neuroendocrine carcinomas and small cell lung carcinomas.Due to the low in-cidence and lack of specific clinical manifestations,the diagnosis and management of pulmonary carcinoid tumors remain relatively challenging.Current consensus supports surgery as the only curative option for localized,resectable pulmonary carcinoid tumors.How-ever,some inconsistencies exist between the guideline recommendations for systemic therapies that have resulted in a lack of consen-sus in regard to the standardized treatment for the metastatic or unresectable disease.This review intends to summarize the latest rec-ommendations for the diagnosis and multidisciplinary treatment of pulmonary carcinoid tumors.
